As the second leading cause of death worldwide, cancer is a focal point in both clinical research and health care fields, but not all cancers are created equal. While some cancers are now much less deadly due to recent medical advances, other aggressive cancers remain highly resistant to currently available therapies.Continue reading
Author Archive: AZBio
Makers of Brainwave Optimization Technologies® and Cereset™ Announce New Clinical Trial for Mild-Traumatic Brain Injury
Military personnel, athletes and accident victims who experience concussions can suffer from painful and debilitating conditions that impact everyday activities. Persisting symptoms from these mild Traumatic Brain Injuries (mTBI) can include sleep disturbance, anxiety, depression, foggy thinking, headaches, dizziness and behavioral issues.Continue reading
NuvOx Pharma’s NVX-208 Shows Positive Results in Phase Ib/II Stroke Trial
Positive results of NuvOx Pharma’s NVX-208 in the treatment of stroke have been published at the International Stroke Conference. The trial was sponsored by the University of Arkansas for Medical Sciences. William “Bill” Culp, MD, the principal investigator on the trial, said, “Such strong safety and promising efficacy results meet our highest hopes for this small trial. Expanded trials are fully warranted.”Continue reading
Researchers to Compete in ‘Shark Tank,’ Demo Technology, More at Research Day, Feb. 13
University of Arizona researchers will compete in a “Shark Tank”-style competition, demonstrate their medical technology and more during Research Day, a first-of-its-kind event coordinated by the UA College of Medicine – TucsonContinue reading
Tucson High Schoolers to Explore Careers in Medicine, Other Health Professions, Feb. 20
Local high school students will practice their health-care skills, such as CPR and ultrasound imaging, during “A Pathway to Success,” an interactive health-care career fair spearheaded by residents at the University of Arizona College of Medicine – Tucson South Campus.Continue reading
GT Medical Technologies Announces $10 Million Financing to Support Launch of Targeted Therapy for Patients with Recurrent Brain Tumors
– Company is Focused on Slowing Brain Tumor Progression, Improving Quality of Life for Patients and Caregivers
– Seasoned Life Science Industry Executives Prattipati Laxminarain and Mara Aspinall Join Board of DirectorsContinue reading
Tucson Entrepreneurs Launch Second Fund to Advance UA-Related Startups
UAVenture Capital has launched a second venture capital fund designed specifically to help finance the commercialization of emerging and disruptive technologies formulated by UA researchers, faculty and students.Continue reading
Axolotl Biologix Launches New DualGraft™ For Faster Healing
Regenerative Medicine Patch Advances Wound RepairContinue reading